Texas Oncology-McAllen South Second Street — McAllen, Texas

Texas Oncology-McAllen South Second Street is a clinical research site located in McAllen, Texas, United States 78503.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-McAllen South Second Street has participated in 3 clinical trials.

Therapeutic areas: Pancreatic Cancer Stage IV, Hepatocellular Carcinoma, Metastatic Breast Cancer.

Sponsors: CanBas Co. Ltd., Sumitomo Pharma America, Inc., US Oncology Research.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-McAllen South Second Street?

Texas Oncology-McAllen South Second Street has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-McAllen South Second Street conducted?

Texas Oncology-McAllen South Second Street has 3 clinical trials on record. Their work covers Pancreatic Cancer Stage IV, Hepatocellular Carcinoma, Metastatic Breast Cancer.

Is Texas Oncology-McAllen South Second Street accredited by Crixeo Health?

Texas Oncology-McAllen South Second Street has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-McAllen South Second Street?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.